Company news: AusCann; Avecho; Melodiol Global Health by Steve Jones April 30, 2024July 16, 2024 AusCann has loaned a further A$500,000 to its European partner Eurocann as the two companies continue […]
Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024
Melodiol ‘evaluating proposal’ to sell ‘various core assets’ by Steve Jones January 17, 2024July 11, 2024
Melodiol targets Health House growth amid plans to streamline portfolio by Steve Jones August 2, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
Company news: MediCann Health; Creso Pharma; Botanix Pharmaceuticals; Incannex by Martin Lane September 7, 2022April 29, 2024
Company news: Helius Therapeutics; Greenfern Industries; Tilray; Creso Pharma; Live Verdure by Martin Lane September 1, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
‘We needed an Aussie operation,’ says Creso boss, as expansion talks begin with Health House International by Steve Jones August 4, 2022April 29, 2024
